biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	49D1BE4B-21CF-4930-8004-1F1E42E55ABD
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AAEG-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AAEG-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AAEG-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788078
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-DD-AAEG.B48B65B0-92F9-4B49-B8A8-563EA5AF70F1.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A39J
biospecimen__bio__plate_row	E
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AAEG
biospecimen__shared__patient_id	AAEG
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	955D8FF4-E963-46E7-B9D6-B688D68370E5
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	3.0
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	1
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.3
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	59
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AAEG-F68430
clinical__clin_shared__bcr_followup_uuid	6F4227E6-BD6F-4F25-9855-02C80D5934E4
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	69
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	Yes
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a2606596-f252-4c14-8eb7-bbae8c75e7fa
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AAEG-01A-11R-A39J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	4bb68077-d35a-400f-8920-4f97d8c7639f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	8de4e99f-aca1-4517-9d01-fec7f53b08f4
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	bd627786-31a8-46d9-b3e2-7f489d50f608
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:30:09.587137-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	a55fbe11-4113-52ae-b17f-206a4df5c78c
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1953
gdc__diagnoses__age_at_diagnosis	21853
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-21853.0
gdc__diagnoses__days_to_last_follow_up	719.0
gdc__diagnoses__diagnosis_id	94d2474f-93de-50cd-8021-f29c706a5cf6
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	18.017206432142697
gdc__exposures__exposure_id	2f41a806-5278-57b6-b6e8-54ec69e07e65
gdc__exposures__height	149.0
gdc__exposures__weight	40.0
gdc__file_id	fd509a9b-e17d-474d-9cda-d9321653f187
gdc__file_name	26430cf4-543a-425c-99ad-f2897a850aea.mirbase21.mirnas.quantification.txt
gdc__file_size	50247
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	c742fe0ab378439add0c4d08adadf7a6
gdc__portions__is_ffpe	false
gdc__portions__portion_id	4d3bc033-579e-49bb-99f2-1292bcdbe4b6
gdc__portions__portion_number	11
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	529
gdc__samples__initial_weight	20.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	B48B65B0-92F9-4B49-B8A8-563EA5AF70F1
gdc__samples__sample_id	e8159d19-97f4-4690-b60b-40080d1e83eb
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	992f86b6-da95-4f0e-8004-36e094cc8bfc
gdc__submitter_id	mirna_swap_dr11_71_MirnaExpression71cc4c0d-c729-49d3-afb5-25fa01312f94_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	339b26a8-2969-5d11-adf0-79a0cc497852
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:17.467+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a2606596-f252-4c14-8eb7-bbae8c75e7fa-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a2606596-f252-4c14-8eb7-bbae8c75e7fa-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129618
manually_curated__local_md5	c95dfbe640726878bda38badddb5220c
manually_curated__opengdc_download_date	2018-10-16T17:10:47.000066+02:00
manually_curated__opengdc_file_md5	cf566efc41f2a906db50e8375f5434bf
manually_curated__opengdc_file_size	50246
manually_curated__opengdc_id	a2606596-f252-4c14-8eb7-bbae8c75e7fa-meq
manually_curated__origin_file_size	129618
manually_curated__origin_last_modified_date	Tue Oct 16 17:22:00 CEST 2018
manually_curated__origin_md5	c95dfbe640726878bda38badddb5220c
manually_curated__tissue_status	tumoral
